A review in Genes & Diseases highlights a source of molecules that could help detect and treat human disease:
proteins and peptides produced from RNA once considered noncoding. The article examines these molecules alongside
exosomes, tiny packages that carry biological messages between cells, outlining opportunities for diagnosis, disease monitoring and targeted treatment.
Prepared by a team at Fujian Medical University and Fujian Maternity and Child Health Hospital, the review brings together evidence spanning nine physiological systems. It explores how exosome-derived noncoding RNA-encoded polypeptides and proteins, termed
EDNEPs, may influence processes ranging from tumor growth to inflammation and heart function.
Noncoding RNAs were traditionally understood to regulate genes without providing instructions for proteins. Some, however, contain sequences that can be translated into functional peptides or proteins. This capability expands the ways these RNAs can influence cellular behavior and challenges assumptions about their roles.
Exosomes provide another layer of communication. Released by cells and present in fluids including blood, urine and saliva, these nanoscale vesicles transport RNA, proteins and other cargo. Their contents can affect recipient cells, altering growth, metabolism and immune responses. Their presence in body fluids also makes them attractive candidates for developing
minimally invasive tests.
The review describes how noncoding RNA-encoded molecules can either promote disease or provide protection, depending on their molecular partners and biological setting. In cancer, some support
tumor proliferation, invasion or treatment resistance, while others suppress harmful signaling and slow tumor growth. These contrasting effects create possibilities for both blocking disease-promoting molecules and delivering protective ones.
Potential clinical applications include
biomarkers that help identify disease, estimate prognosis or track changes over time. Therapeutic strategies could involve targeting specific peptides or using exosomes to deliver beneficial molecules to selected tissues. Several examples also suggest opportunities to improve sensitivity to existing anticancer medicines.
However, barriers remain. Exosomes are small and difficult to isolate in sufficient quantities without contamination or damage. The mechanisms linking RNAs, their encoded products and disease outcomes also need clearer validation.
Immune reactions, toxicity and delivery specificity require evaluation before clinical use.
The article highlights purification methods, live-cell imaging and molecular analysis as tools for resolving these challenges. It also calls for broader attention to conditions beyond cancer, including
inflammatory, metabolic and degenerative diseases.
# # # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 10.4 |Impact Factor:14.6
# # # # # #
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available
online in
ScienceDirect (
https://www.sciencedirect.com/journal/genes-and-diseases).
Submissions to
Genes & Diseases may be made using
Editorial Manager (
https://www.editorialmanager.com/gendis/default.aspx).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases (
https://x.com/GenesNDiseases)
# # # # # #
Reference
Xinyuan Feng, Meihuan Chen, Dahang Ye, Ying Zhu, Liangpu Xu, Hailong Huang, Functions of exosome-derived noncoding RNA-encoded polypeptides/proteins in human diseases, Genes & Diseases, Volume 14, Issue 1, 2027, 102128,
https://doi.org/10.1016/j.gendis.2026.102128
Funding
Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province (China)
2023ZQNZD009
National Natural Science Foundation of China
81970170
Joint Funds for the Innovation of Science and Technology of Fujian province (China)
2023Y9364
Fujian Provincial Natural Science Foundation of China
2023J011217
Fujian Provincial Natural Science Foundation of China
2025J011152
Fujian Provincial Natural Science Foundation of China
2025J011153